{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:57:52Z","timestamp":1785293872249,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,1,9]],"date-time":"2007-01-09T00:00:00Z","timestamp":1168300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2007,1,9]],"date-time":"2007-01-09T00:00:00Z","timestamp":1168300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s00109-006-0135-4","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T09:58:58Z","timestamp":1168250338000},"page":"227-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["An unexpected new role of mutant Ras: perturbation of human embryonic development"],"prefix":"10.1007","volume":"85","author":[{"given":"Christian P.","family":"Kratz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Niemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,9]]},"reference":[{"key":"135_CR1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tcb.2004.09.014","volume":"14","author":"GA Repasky","year":"2004","unstructured":"Repasky GA, Chenette EJ, Der CJ (2004) Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trends Cell Biol 14:639\u2013647","journal-title":"Trends Cell Biol"},{"key":"135_CR2","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1126\/science.1062023","volume":"294","author":"IR Vetter","year":"2001","unstructured":"Vetter IR, Wittinghofer A (2001) The guanine nucleotide-binding switch in three dimensions. Science 294:1299\u20131304","journal-title":"Science"},{"key":"135_CR3","first-page":"23","volume":"1602","author":"S Donovan","year":"2002","unstructured":"Donovan S, Shannon KM, Bollag G (2002) GTPase activating poteins: critical regulators of intracellular signaling. BBA Rev Cancer 1602:23\u201345","journal-title":"BBA Rev Cancer"},{"key":"135_CR4","first-page":"4682","volume":"49","author":"JL Bos","year":"1989","unstructured":"Bos JL (1989) Ras oncogenes in human cancer: a review. Cancer Res 49:4682\u20134689","journal-title":"Cancer Res"},{"key":"135_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1535-6108(04)00085-6","volume":"5","author":"DA Tuveson","year":"2004","unstructured":"Tuveson DA, Shaw AT, Willis NA, Silver DP, Jackson EL, Chang S, Mercer KL, Grochow R, Hock H, Crowley D, Hingorani SR, Zaks T, King C, Jacobetz MA, Wang L, Bronson RT, Orkin SH, DePinho RA, Jacks T (2004) Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5:375\u2013387","journal-title":"Cancer Cell"},{"key":"135_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.genom.6.080604.162305","volume":"6","author":"M Tartaglia","year":"2005","unstructured":"Tartaglia M, Gelb BD (2005) Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet 6:45\u201368","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"135_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ajmg.c.10019","volume":"117","author":"RC Hennekam","year":"2003","unstructured":"Hennekam RC (2003) Costello syndrome: an overview. Am J Med Genet C Semin Med Genet 117:42\u201348","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"135_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ajmg.10681","volume":"112","author":"MI Kavamura","year":"2002","unstructured":"Kavamura MI, Peres CA, Alchorne MM, Brunoni D (2002) CFC index for the diagnosis of cardiofaciocutaneous syndrome. Am J Med Genet 112:12\u201316","journal-title":"Am J Med Genet"},{"key":"135_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/1096-8628(20000904)94:1<46::AID-AJMG10>3.0.CO;2-I","volume":"94","author":"I van der Burgt","year":"2000","unstructured":"van der Burgt I, Brunner H (2000) Genetic heterogeneity in Noonan syndrome: evidence for an autosomal recessive form. Am J Med Genet 94:46\u201351","journal-title":"Am J Med Genet"},{"key":"135_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ng1294-357","volume":"8","author":"CR Jamieson","year":"1994","unstructured":"Jamieson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, Jeffery S, Patton MA, Mariman E (1994) Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet 8:357\u2013359","journal-title":"Nat Genet"},{"key":"135_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465\u2013468","journal-title":"Nat Genet"},{"key":"135_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","volume":"28","author":"BG Neel","year":"2003","unstructured":"Neel BG, Gu H, Pao L (2003) The \u2018Shp\u2019ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28:284\u2013293","journal-title":"Trends Biochem Sci"},{"key":"135_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1086\/341528","volume":"71","author":"MC Digilio","year":"2002","unstructured":"Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, Pizzuti A, Dallapiccola B (2002) Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 71:389\u2013394","journal-title":"Am J Hum Genet"},{"key":"135_CR14","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1074\/jbc.M513068200","volume":"281","author":"MI Kontaridis","year":"2006","unstructured":"Kontaridis MI, Swanson KD, David FS, Barford D, Neel BG (2006) PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. J Biol Chem 281:6785\u20136792","journal-title":"J Biol Chem"},{"key":"135_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/499925","volume":"78","author":"M Tartaglia","year":"2006","unstructured":"Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, Zampino G, Burgt I, Palleschi A, Petrucci TC, Sorcini M, Schoch C, Foa R, Emanuel PD, Gelb BD (2006) Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 78:279\u2013290","journal-title":"Am J Hum Genet"},{"key":"135_CR16","first-page":"3534","volume":"89","author":"CM Niemeyer","year":"1997","unstructured":"Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, Haas O, Harbott J, Hasle H, Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, van\u2019t Veer-Korthof ET, van Wering E, Zimmermann M (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 89:3534\u20133543","journal-title":"Blood"},{"key":"135_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/sj\/leu\/2401240","volume":"13","author":"C Flotho","year":"1999","unstructured":"Flotho C, Valcamonica S, Mach-Pascual S, Schmahl G, Corral L, Ritterbach J, Hasle H, Arico M, Biondi A, Niemeyer CM (1999) RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 13:32\u201337","journal-title":"Leukemia"},{"key":"135_CR18","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/blood.V84.10.3435.3435","volume":"84","author":"R Kalra","year":"1994","unstructured":"Kalra R, Paderanga DC, Olson K, Shannon KM (1994) Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Blood 84:3435\u20133439","journal-title":"Blood"},{"key":"135_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/pbc.20644","volume":"46","author":"JO Lauchle","year":"2006","unstructured":"Lauchle JO, Braun BS, Loh ML, Shannon K (2006) Inherited predispositions and hyperactive Ras in myeloid leukemogenesis. Pediatr Blood Cancer 46:579\u2013585","journal-title":"Pediatr Blood Cancer"},{"key":"135_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1073\/pnas.0307203101","volume":"101","author":"BS Braun","year":"2004","unstructured":"Braun BS, Tuveson DA, Kong N, Le DT, Kogan SC, Rozmus J, Le Beau MM, Jacks TE, Shannon KM (2004) Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci U S A 101:597\u2013602","journal-title":"Proc Natl Acad Sci U S A"},{"key":"135_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1172\/JCI200420476","volume":"113","author":"IT Chan","year":"2004","unstructured":"Chan IT, Kutok JL, Williams IR, Cohen S, Kelly L, Shigematsu H, Johnson L, Akashi K, Tuveson DA, Jacks T, Gilliland DG (2004) Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest 113:528\u2013538","journal-title":"J Clin Invest"},{"key":"135_CR22","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0022-3476(97)70273-7","volume":"130","author":"B Bader-Meunier","year":"1997","unstructured":"Bader-Meunier B, Tchernia G, Mielot F, Fontaine JL, Thomas C, Lyonnet S, Lavergne JM, Dommergues JP (1997) Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 130:885\u2013889","journal-title":"J Pediatr"},{"key":"135_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1156","volume":"34","author":"M Tartaglia","year":"2003","unstructured":"Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hahlen K, Hasle H, Licht JD, Gelb BD (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148\u2013150","journal-title":"Nat Genet"},{"key":"135_CR24","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","volume":"103","author":"ML Loh","year":"2004","unstructured":"Loh ML, Vattikuti S, Schubbert S, Reynolds MG, Carlson E, Lieuw KH, Cheng JW, Lee CM, Stokoe D, Bonifas JM, Curtiss NP, Gotlib J, Meshinchi S, Le Beau MM, Emanuel PD, Shannon KM (2004) Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103:2325\u20132331","journal-title":"Blood"},{"key":"135_CR25","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1182\/blood-2005-02-0531","volume":"106","author":"CP Kratz","year":"2005","unstructured":"Kratz CP, Niemeyer CM, Castleberry RP, Cetin M, Bergstrasser E, Emanuel PD, Hasle H, Kardos G, Klein C, Kojima S, Stary J, Trebo M, Zecca M, Gelb BD, Tartaglia M, Loh ML (2005) The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease. Blood 106:2183\u20132185","journal-title":"Blood"},{"key":"135_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/blood-2003-11-3876","volume":"104","author":"M Tartaglia","year":"2004","unstructured":"Tartaglia M, Martinelli S, Cazzaniga G, Cordeddu V, Iavarone I, Spinelli M, Palmi C, Carta C, Pession A, Arico M, Masera G, Basso G, Sorcini M, Gelb BD, Biondi A (2004) Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood 104:307\u2013313","journal-title":"Blood"},{"key":"135_CR27","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.1158\/0008-5472.CAN-04-1923","volume":"64","author":"M Bentires-Alj","year":"2004","unstructured":"Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG (2004) Activating mutations of the Noonan syndrome-associated SHP2\/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res 64:8816\u20138820","journal-title":"Cancer Res"},{"key":"135_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1182\/blood-2004-11-4207","volume":"106","author":"S Schubbert","year":"2005","unstructured":"Schubbert S, Lieuw K, Rowe SL, Lee CM, Li X, Loh ML, Clapp DW, Shannon KM (2005) Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood 106:311\u2013317","journal-title":"Blood"},{"key":"135_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ccr.2005.01.010","volume":"7","author":"MG Mohi","year":"2005","unstructured":"Mohi MG, Williams IR, Dearolf CR, Chan G, Kutok JL, Cohen S, Morgan K, Boulton C, Shigematsu H, Keilhack H, Akashi K, Gilliland DG, Neel BG (2005) Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 7:179\u2013191","journal-title":"Cancer Cell"},{"issue":"9","key":"135_CR30","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1182\/blood-2004-10-4002","volume":"105","author":"RJ Chan","year":"2005","unstructured":"Chan RJ, Leedy MB, Munugalavadla V, Voorhorst CS, Li Y, Yu M, Kapur R (2005) Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor. Blood 105(9):3737-3742","journal-title":"Blood"},{"key":"135_CR31","doi-asserted-by":"publisher","first-page":"30984","DOI":"10.1074\/jbc.M504699200","volume":"280","author":"H Keilhack","year":"2005","unstructured":"Keilhack H, David FS, McGregor M, Cantley LC, Neel BG (2005) Diverse biochemical properties of Shp2 mutants: implications for disease phenotypes. J Biol Chem 280:30984\u201330993","journal-title":"J Biol Chem"},{"key":"135_CR32","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nm1084","volume":"10","author":"T Araki","year":"2004","unstructured":"Araki T, Mohi MG, Ismat FA, Bronson RT, Williams IR, Kutok JL, Yang W, Pao LI, Gilliland DG, Epstein JA, Neel BG (2004) Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat Med 10:849\u2013857","journal-title":"Nat Med"},{"key":"135_CR33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V92.1.267.413a31_267_272","volume":"92","author":"L Side","year":"1998","unstructured":"Side L, Emanuel P, Taylor B, Franklin J, Thompson P, Castleberry R, Shannon K (1998) Mutations of the NF1 gene in leukemias from children without evidence of neurofibromatosis, type 1. Blood 92:267\u2013273","journal-title":"Blood"},{"key":"135_CR34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/NEJM199403033300903","volume":"330","author":"KM Shannon","year":"1994","unstructured":"Shannon KM, O\u2019Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F (1994) Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597\u2013601","journal-title":"N Engl J Med"},{"key":"135_CR35","doi-asserted-by":"crossref","unstructured":"Stephens K, Weaver M, Leppig KA, Maruyama K, Emanuel PD, Le Beau MM, Shannon KM (2006) Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood","DOI":"10.1182\/blood-2005-11-011486"},{"key":"135_CR36","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ng0296-144","volume":"12","author":"G Bollag","year":"1996","unstructured":"Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K (1996) Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 12:144\u2013148","journal-title":"Nat Genet"},{"key":"135_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ng0296-137","volume":"12","author":"DA Largaespada","year":"1916","unstructured":"Largaespada DA, Brannan CI, Jenkins NA, Copeland NG (1996) Nf1 deficiency causes Ras-mediated granulocyte\/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nat Genet 12:137\u2013143","journal-title":"Nat Genet"},{"key":"135_CR38","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1182\/blood-2003-08-2650","volume":"103","author":"DT Le","year":"2004","unstructured":"Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, Wang E, Kogan SC, Le Beau MM, Parada L, Shannon KM (2004) Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood 103:4243\u20134250","journal-title":"Blood"},{"key":"135_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1399-0004.1996.tb04328.x","volume":"49","author":"A Colley","year":"1996","unstructured":"Colley A, Donnai D, Evans DG (1996) Neurofibromatosis\/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Clin Genet 49:59\u201364","journal-title":"Clin Genet"},{"key":"135_CR40","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1086\/498454","volume":"77","author":"A De Luca","year":"2005","unstructured":"De Luca A, Bottillo I, Sarkozy A, Carta C, Neri C, Bellacchio E, Schirinzi A, Conti E, Zampino G, Battaglia A, Majore S, Rinaldi MM, Carella M, Marino B, Pizzuti A, Digilio MC, Tartaglia M, Dallapiccola B (2005) NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. Am J Hum Genet 77:1092\u20131101","journal-title":"Am J Hum Genet"},{"key":"135_CR41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jpeds.2003.11.032","volume":"144","author":"M Zenker","year":"2004","unstructured":"Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W, Tietze HU, Doerr HG, Hofbeck M, Singer H, Reis A, Rauch A (2004) Genotype\u2013phenotype correlations in Noonan syndrome. J Pediatr 144:368\u2013374","journal-title":"J Pediatr"},{"key":"135_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng1748","volume":"38","author":"S Schubbert","year":"2006","unstructured":"Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, van der Burgt I, Musante L, Kalscheuer V, Wehner LE, Nguyen H, West B, Zhang KY, Sistermans E, Rauch A, Niemeyer CM, Shannon K, Kratz CP (2006) Germline KRAS mutations cause Noonan syndrome. Nat Genet 38:331\u2013336","journal-title":"Nat Genet"},{"key":"135_CR43","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/ng1641","volume":"37","author":"Y Aoki","year":"2005","unstructured":"Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, Filocamo M, Kato K, Suzuki Y, Kure S, Matsubara Y (2005) Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 37:1038\u20131040","journal-title":"Nat Genet"},{"key":"135_CR44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/ng1749","volume":"38","author":"T Niihori","year":"2006","unstructured":"Niihori T, Aoki Y, Narumi Y, Neri G, Cave H, Verloes A, Okamoto N, Hennekam RC, Gillessen-Kaesbach G, Wieczorek D, Kavamura MI, Kurosawa K, Ohashi H, Wilson L, Heron D, Bonneau D, Corona G, Kaname T, Naritomi K, Baumann C, Matsumoto N, Kato K, Kure S, Matsubara Y (2006) Germline KRAS and BRAF mutations in cardio\u2013facio\u2013cutaneous syndrome. Nat Genet 38:294\u2013296","journal-title":"Nat Genet"},{"key":"135_CR45","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1126\/science.1124642","volume":"311","author":"P Rodriguez-Viciana","year":"2006","unstructured":"Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA (2006) Germline mutations in genes within the MAPK pathway cause cardio\u2013facio\u2013cutaneous syndrome. Science 311:1287\u20131290","journal-title":"Science"},{"key":"135_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1086\/504394","volume":"79","author":"C Carta","year":"2006","unstructured":"Carta C, Pantaleoni F, Bocchinfuso G, Stella L, Vasta I, Sarkozy A, Digilio C, Palleschi A, Pizzuti A, Grammatico P, Zampino G, Dallapiccola B, Gelb BD, Tartaglia M (2006) Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. Am J Hum Genet 79:129\u2013135","journal-title":"Am J Hum Genet"},{"key":"135_CR47","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00149-1","volume":"112","author":"SM Margarit","year":"2003","unstructured":"Margarit SM, Sondermann H, Hall BE, Nagar B, Hoelz A, Pirruccello M, Bar-Sagi D, Kuriyan J (2003) Structural evidence for feedback activation by Ras. GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112:685\u2013695","journal-title":"Cell"},{"key":"135_CR48","doi-asserted-by":"crossref","unstructured":"Zenker M, Lehmann K, Schulz AL, Barth CF, Hansmann D, Koenig R, Korinthenberg R, Kreiss-Nachtsheim M, Meinecke P, Morlot S, Mundlos S, Quante AS, Raskin S, Schnabel D, Wehner LE, Kratz CP, Horn D, Kutsche K (2006) Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet 2006 Oct 20; [Epub ahead of print]","DOI":"10.1136\/jmg.2006.046300"},{"key":"135_CR49","first-page":"7311","volume":"13","author":"JC Stone","year":"1993","unstructured":"Stone JC, Colleton M, Bottorff D (1993) Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction. Mol Cell Biol 13:7311\u20137320","journal-title":"Mol Cell Biol"},{"key":"135_CR50","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"key":"135_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.31047","volume":"140","author":"KW Gripp","year":"2006","unstructured":"Gripp KW, Lin AE, Stabley DL, Nicholson L, Scott CI, Jr., Doyle D, Aoki Y, Matsubara Y, Zackai EH, Lapunzina P, Gonzalez-Meneses A, Holbrook J, Agresta CA, Gonzalez IL, Sol-Church K (2006) HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation. Am J Med Genet A 140:1\u20137","journal-title":"Am J Med Genet A"},{"key":"135_CR52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/jmg.2005.040352","volume":"43","author":"B Kerr","year":"2006","unstructured":"Kerr B, Delrue MA, Sigaudy S, Perveen R, Marche M, Burgelin I, Stef M, Tang B, Eden OB, O\u2019Sullivan J, De Sandre-Giovannoli A, Reardon W, Brewer C, Bennett C, Quarell O, M\u2019Cann E, Donnai D, Stewart F, Hennekam R, Cave H, Verloes A, Philip N, Lacombe D, Levy N, Arveiler B, Black G (2006) Genotype\u2013phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet 43:401\u2013405","journal-title":"J Med Genet"},{"key":"135_CR53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.a.31078","volume":"140","author":"AL Estep","year":"2006","unstructured":"Estep AL, Tidyman WE, Teitell MA, Cotter PD, Rauen KA (2006) HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy. Am J Med Genet A 140:8\u201316","journal-title":"Am J Med Genet A"},{"key":"135_CR54","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1101\/gad.11.19.2468","volume":"11","author":"L Johnson","year":"1997","unstructured":"Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R, Jacks T (1997) K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 11:2468\u20132481","journal-title":"Genes Dev"},{"key":"135_CR55","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1146\/annurev.immunol.24.021605.090723","volume":"24","author":"A Mor","year":"2006","unstructured":"Mor A, Philips MR (2006) Compartmentalized Ras\/MAPK signaling. Annu Rev Immunol 24:771\u2013800","journal-title":"Annu Rev Immunol"},{"key":"135_CR56","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1126\/science.1105654","volume":"307","author":"O Rocks","year":"2005","unstructured":"Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, Lumbierres M, Kuhlmann J, Waldmann H, Wittinghofer A, Bastiaens PI (2005) An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307:1746\u20131752","journal-title":"Science"},{"key":"135_CR57","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/ajmg.a.31315","volume":"140","author":"KA Rauen","year":"2006","unstructured":"Rauen KA (2006) Distinguishing Costello versus cardio\u2013facio\u2013cutaneous syndrome: BRAF mutations in patients with a Costello phenotype. Am J Med Genet 140:1681\u20131683","journal-title":"Am J Med Genet"},{"key":"135_CR58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nm0306-283","volume":"12","author":"M Bentires-Alj","year":"2006","unstructured":"Bentires-Alj M, Kontaridis MI, Neel BG (2006) Stops along the RAS pathway in human genetic disease. Nat Med 12:283\u2013285","journal-title":"Nat Med"},{"key":"135_CR59","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/ajmg.a.31547","volume":"140","author":"U H\u00fcffmeier","year":"2006","unstructured":"H\u00fcffmeier U, Zenker M, Hoyer J, Fahsold R, Rauch A (2006) A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene. Am J Med Genet A 140:2749\u20132756","journal-title":"Am J Med Genet A"},{"key":"135_CR60","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ajmg.a.30813","volume":"136","author":"DR Bertola","year":"2005","unstructured":"Bertola DR, Pereira AC, Passetti F, de Oliveira PS, Messiaen L, Gelb BD, Kim CA, Krieger JE (2005) Neurofibromatosis\u2013Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient. Am J Med Genet A 136:242\u2013245","journal-title":"Am J Med Genet A"},{"key":"135_CR61","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.4161\/cc.5.15.3128","volume":"5","author":"CP Kratz","year":"2006","unstructured":"Kratz CP, Schubbert S, Bollag G, Niemeyer CM, Shannon KM, Zenker M (2006) Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders. Cell Cycle 5:1607\u20131611","journal-title":"Cell Cycle"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-006-0135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-006-0135-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-006-0135-4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-006-0135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T16:45:08Z","timestamp":1630428308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-006-0135-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1007\/s00109-006-0135-4","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,9]]},"assertion":[{"value":"22 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}